Phebra has acquired a group of critical sterile products from Mayne Pharma for the Australian and Asian markets.

• Methadone Injection 10mg in 1mL (NZ Only)
• Indigo Carmine Injection 20mg in 5mL
• Ascorbic Acid Injection 500mg in 5mL
• Dehydrated Alcohol Injection 20mL
• Paraldehyde Injection 5mL
• Oily Phenol Injection 250mg in 5mL 

Phebra will be the products sponsor from the 23rd March 2007, and will continue to sell Mayne stock while the site of manufacture is changed to Phebra’s Sydney plant.

The Acquisition of these Mayne products assists customers with guaranteed supply.

Phebra is undertaking a major regulatory review of each product. All products, with the exception of Oily Phenol, are available immediately.

The Oily Phenol is expected to be available from June 2007.